Previous 10 | Next 10 |
Penny Stocks To Buy For Under $5; Are They Worth The Risk? There are so many traders in the stock market today searching for top penny stocks to buy. These high-risk assets have been a source for some of the biggest winning trades over the last few years. I’m not only talking abo...
ARCA biopharma (NASDAQ:ABIO) announces that enrollment has been completed in Phase 2b ASPEN-COVID-19 trial evaluating rNAPc2 as a potential treatment for patients hospitalized with COVID-19. Shares up 5.3% premarket at $2.39. 160 patients were enrolled at clinical sites in U.S....
Topline readout of clinical trial results anticipated in first quarter of 2022 WESTMINSTER, Colo., Dec. 02, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing targeted therapies...
Small and Micro-cap investors are invited to attend the Q4 Investor Summit being held on November 16-17, 2021. The event is organized by the Investor Summit Group, recognised as a highly reputed brand for hosting North America’s largest independent investor conferences. Over 90 pre...
WESTMINSTER, Colo., Nov. 09, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced that Tom Keuer , Chief Operating Of...
On-going Phase 2b clinical trial (ASPEN-COVID-19) evaluating rNAPc2 as a potential treatment for COVID-19 DSMC interim analysis of safety and efficacy data from ASPEN-COVID-19 completed with recommendation to continue trial to completion with no modifications T...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! It’s the last day of the trading week and we’re starting it with a dive into the biggest pre-market stock movers for Friday! Source: f11photo/Shutterstock.com We’ve got p...
ARCA biopharma (NASDAQ:ABIO) announces that the Data and Safety Monitoring Committee (DSMC) has recommended completing the company's Phase 2b study of rNAPc2 in treating COVID-19 with no modifications to the trial design. Shares jump more than 30% post market. The rec...
Enrollment completion anticipated by year end 2021 Topline data anticipated in first quarter of 2022 WESTMINSTER, Colo., Oct. 28, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approac...
Direxion is planning to launch the Direxion mRNA ETF to offer investors exposure to messenger RNA technology, the cutting-edge research area that served as the basis for most COVID-19 vaccines. Per a prospectus filed with the U.S. Securities and Exchange Commission, the new ETF will...
News, Short Squeeze, Breakout and More Instantly...
Bank of the James Financial Group Inc. (BOTJ) is expected to report for Q2 2024 Electrolux AB ADR (ELUXY) is expected to report $-0.18 for Q2 2024 Coca Cola Femsa S.A.B. de C.V. American Depositary Shares each representing 10 Units (each Unit consists of 3 Series B Shares and 5 Series L S...
NEW YORK, NY / ACCESSWIRE / May 22, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Squarespace, Inc. (NYSE:SQSP)'s sale...